Jim Baum

Parametric Technology Corporation (1989-2000)

James P. Baum is the President and COO of Endeca, a provider of software solutions for firms that need to integrate, organize, and navigate enterprise data. Before Endeca, Jim was at the EVP and General Manager of Windchill at PTC, responsible for PTC's Windchill business unit. In this role, Jim had responsibility for the P&L, product strategy, product development, marketing, operations, and services aspects of the Windchill business. His previous role at PTC was the Executive Vice President of Engineering, Research and Development. Mr. Baum's responsibilities included technical product marketing, strategy, development, and delivery functions for all of PTC's products including flexible engineering and collaborative product commerce applications. In addition, he defined and executed PTC's acquisition strategy related to identification of target companies, technical due diligence, and organizational integration.

Dr. Joseph Bonventre

Harvard-MIT Division of Health Sciences and Technology

Dr. Bonventre is a Professor of Molecular Medicine at Harvard Medical School, Director of the Harvard-MIT Division of Health Sciences and Technology, and Master of the Harvard-MIT Division of Health Sciences and Technology Society at Harvard Medical School. Joe will bring crucial guidance to Actuality's application of 3D display technology to medical imaging for clinical and educational use.

Dr. Bonventre is past President of the Massachusetts and Rhode Island chapter of the National Kidney Foundation, is Chairman of the Public Affairs Committee of the National Kidney Foundation, and is on the Scientific Advisory Board of the National Kidney Foundation. He is a member of the NIH General Medicine B Study Section. He won a Young Investigator Award of the NIH and the Presidential Award of the Microbeam Society and has been elected to several prestigious societies including the American Society for Clinical Investigation and the Association of American Physicians. He is a Board member of both the National Space Biology Research Institute and the Center for Engineering in Medicine at Harvard Medical School.

Dr. Bonventre is on a Board of Advisors of the Norwegian Institute for Science and Technology, is a founder and is on the Board of Directors of PatientKeeper, Inc. , is on the Scientific Advisory Boards of GelTex Pharmaceutical Company , Advanced Medicine Inc. , and SamTex Corp., and is a member of the Physician Advisory Board of Genzyme, Inc.

Specializing in kidney disease research, Dr. Bonventre has established models of ischemic acute renal failure, toxic nephropathy, and glomerular injury. He has over 120 publications and 46 invited chapters and reviews, and is the author or editor of three books. Dr. Bonventre holds a B.S. in Engineering Physics (Cornell) and an M.D. and Ph.D. in Biophysics (Harvard). He completed Internal Medicine and Nephrology clinical training at the MGH and is Board Certified in both.

Dr. Michael Halle

Brigham and Women's Hospital

Dr. Michael Halle is an Instructor at the Surgical Planning Lab at Brigham and Woman's Hospital, a teaching affiliate of Harvard Medical School. His research includes 3D displays, computer graphics, data visualization, user interface design, software and systems architecture, and networked applications.

Dr. Halle trained as a computer scientist and engineer at MIT, receiving his bachelor's degree in 1988. He received both master's (1991) and doctoral (1997) degrees while working at the MIT Media Lab in holographic imaging and 3-D displays under the guidance of Prof. Stephen Benton. At MIT, Dr. Halle developed computer algorithms for creating some of the world's most advanced 3-D displays. His research included the first characterization of sampling artifacts in holographic stereograms and other 3-D displays, the first complete description of generalized computer predistortion compensation for flat-format HPO holographic stereograms, and the most efficient known method for generating views for full-parallax holographic stereograms using hardware acceleration.

Dr. Michael Hercher

OPTRA

Dr. Michael Hercher received his PhD from the University of Rochester's Institute of Optics in 1963. He stayed at the Institute of Optics for 11 years, becoming a Professor and Associate Dean for Graduate Studies in the College of Engineering. He was a founder and VP for R&D of Coherent Optics, which marketed the first tunable dye laser in the early 1970s. His technical interests are lasers, laser-based metrology, interferometry, high-resolution spectroscopy, and optical instrument design. He has developed three different products that have won IR&D-100 awards. In 1980 he was a founder of OPTRA, Inc., where he is currently its Chief Technical Officer and a member of the Board. He is a Fellow of the Optical Society of America, holder of more than a dozen patents on optical instruments, and has published 70+ papers on optical instrument design, interferometry, and metrology.

Bill Aulet

Viisage Technology (CFO and SVP)
SensAble Technologies (Former President)

Bill Aulet joined Viisage Technology in 2003 as CFO. He most recently served as President of SensAble Technologies, a 3D force feedback systems company, where he handled all operational aspects of the company.

Bill has an undergraduate degree from Harvard University and a graduate degree from the MIT Sloan School of Management where he was a Sloan Fellow. He has served on the boards of a number of organizations, including the Society of Sloan Fellows, Cambridge Decision Dynamics, SensAble Technologies, and the Hoops for Kids Program. Bill is also a Senior Lecturer at the MIT Sloan School of Management.